A remarkable difference was revealed between MCF-7 cells exposed to CM derived from TNFα + TGFβ1-stimulated MSCs (Group 4) and cancer cells exposed to the two other relevant treatments: CM of vehicle-treated MSCs (Group 3) or to the two cytokines only (Group 2). This evidence concerns the gene TGFB1 and cancer.